About Regina Barzilay, Ph.D.
Regina Barzilay, Ph.D. is a director at Dewpoint Therapeutics.
Regina Barzilay, Ph.D. first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Regina Barzilay, Ph.D. in the role, so the role may have started earlier or lasted longer.
Dewpoint Therapeutics, Inc.
Director
2022 – 2026 · Boston, MA
Develops drug candidates for people with cancer and neurological diseases.
Key Colleagues at Startups
The people Regina Barzilay, Ph.D. works with at each company, as listed on that company's latest Form D.
Dewpoint Therapeutics, Inc. · Form D/A, Jul 13, 2026
ID
Isaac Klein, M.D., Ph.D.
Chief Scientific Officer and Head of R&D
SD
Steven Neier, Ph.D.
Director
AD
Ameet Nathwani, M.D.
Chief Executive Officer and director
GD
Giuseppe Ciaramella, Ph.D.
Director
MD
Mark Murcko, Ph.D.
Director
SD
Srinivas Akkaraju, M.D., Ph.D.
Director
OD
Olivier Brandicourt, M.D.
Director
AD
Anthony Hyman, Ph.D.
Director
AD
Amir Nashat, Sc.D.
Director
RD
Richard Young, Ph.D.
Director